222 related articles for article (PubMed ID: 9951684)
1. New p53-based anti-cancer therapeutic strategies.
Wiman KG
Med Oncol; 1998 Dec; 15(4):222-8. PubMed ID: 9951684
[TBL] [Abstract][Full Text] [Related]
2. Targeting p53 in cancer.
Chène P
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):151-61. PubMed ID: 12678764
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic exploitation of the p53 pathway.
Lane DP; Lain S
Trends Mol Med; 2002; 8(4 Suppl):S38-42. PubMed ID: 11927286
[TBL] [Abstract][Full Text] [Related]
4. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
5. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
6. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
7. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus p53 gene therapy.
Roth JA
Expert Opin Biol Ther; 2006 Jan; 6(1):55-61. PubMed ID: 16370914
[TBL] [Abstract][Full Text] [Related]
9. Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.
Li Y; Li B; Li CJ; Li LJ
Expert Opin Biol Ther; 2015 Mar; 15(3):437-54. PubMed ID: 25496374
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy in human cancer: report of human clinical trials.
Wasil T; Buchbinder A
Cancer Invest; 2000; 18(8):740-6. PubMed ID: 11107444
[No Abstract] [Full Text] [Related]
11. p53 as a therapeutic target.
Staples OD; Steele RJ; Lain S
Surgeon; 2008 Aug; 6(4):240-3. PubMed ID: 18697367
[TBL] [Abstract][Full Text] [Related]
12. [New transcription factor-based cancer therapy. Gene therapy, cell lysis, reactivation of p53 are the new approaches].
Wiman KG
Lakartidningen; 1997 Sep; 94(38):3268-72. PubMed ID: 9379794
[TBL] [Abstract][Full Text] [Related]
13. p53 and human cancers.
Lane DP
Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances on p53 gene therapy].
Zhang YY; Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):48-50. PubMed ID: 16608652
[No Abstract] [Full Text] [Related]
16. Small molecules that reactivate mutant p53.
Bykov VJ; Selivanova G; Wiman KG
Eur J Cancer; 2003 Sep; 39(13):1828-34. PubMed ID: 12932659
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in p53 research and cancer treatment.
Suzuki K; Matsubara H
J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
[TBL] [Abstract][Full Text] [Related]
18. Methods for screening tumors for p53 status and therapeutic exploitation.
Tullo A; D'Erchia AM; Sbisà E
Expert Rev Mol Diagn; 2003 May; 3(3):289-301. PubMed ID: 12779005
[TBL] [Abstract][Full Text] [Related]
19. Functional repair of p53 mutation in colorectal cancer cells using trans-splicing.
He X; Liao J; Liu F; Yan J; Yan J; Shang H; Dou Q; Chang Y; Lin J; Song Y
Oncotarget; 2015 Feb; 6(4):2034-45. PubMed ID: 25576916
[TBL] [Abstract][Full Text] [Related]
20. p53: balancing tumour suppression and implications for the clinic.
Buganim Y; Rotter V
Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]